HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,957 | -18.9% | 63,066 | -8.6% | 0.00% | – |
| Q2 2023 | $80,083 | -4.9% | 69,037 | +23.8% | 0.00% | – |
| Q1 2023 | $84,209 | -8.7% | 55,768 | +51.2% | 0.00% | – |
| Q4 2022 | $92,233 | -75.2% | 36,893 | -58.0% | 0.00% | – |
| Q3 2022 | $372,000 | +1590.9% | 87,887 | +990.3% | 0.00% | – |
| Q2 2022 | $22,000 | -98.4% | 8,061 | -96.6% | 0.00% | – |
| Q1 2022 | $1,339,000 | -54.1% | 234,120 | -26.7% | 0.00% | -100.0% |
| Q4 2021 | $2,915,000 | +9.9% | 319,257 | +28.7% | 0.00% | 0.0% |
| Q3 2021 | $2,652,000 | +2004.8% | 248,108 | +2957.4% | 0.00% | – |
| Q2 2021 | $126,000 | -94.7% | 8,115 | -94.5% | 0.00% | -100.0% |
| Q1 2021 | $2,397,000 | -13.8% | 147,904 | +12.5% | 0.00% | 0.0% |
| Q4 2020 | $2,782,000 | +104.9% | 131,450 | +43.5% | 0.00% | 0.0% |
| Q3 2020 | $1,358,000 | -19.3% | 91,584 | -19.9% | 0.00% | 0.0% |
| Q2 2020 | $1,683,000 | +14.4% | 114,379 | -8.7% | 0.00% | 0.0% |
| Q1 2020 | $1,471,000 | -36.5% | 125,320 | +27.2% | 0.00% | 0.0% |
| Q4 2019 | $2,315,000 | -48.0% | 98,536 | -59.1% | 0.00% | -50.0% |
| Q3 2019 | $4,455,000 | +33.3% | 240,848 | +34.0% | 0.00% | +100.0% |
| Q2 2019 | $3,341,000 | +140.4% | 179,708 | +215.8% | 0.00% | 0.0% |
| Q1 2019 | $1,390,000 | -73.9% | 56,903 | -72.3% | 0.00% | -50.0% |
| Q4 2018 | $5,328,000 | +94.1% | 205,379 | +136.8% | 0.00% | +100.0% |
| Q3 2018 | $2,745,000 | +36.4% | 86,718 | +67.5% | 0.00% | 0.0% |
| Q2 2018 | $2,012,000 | -66.7% | 51,776 | -76.3% | 0.00% | -66.7% |
| Q1 2018 | $6,039,000 | +745.8% | 218,800 | +454.8% | 0.00% | – |
| Q4 2017 | $714,000 | -2.7% | 39,436 | -13.3% | 0.00% | – |
| Q3 2017 | $734,000 | +73.5% | 45,483 | +49.0% | 0.00% | – |
| Q2 2017 | $423,000 | +144.5% | 30,520 | +164.2% | 0.00% | – |
| Q1 2017 | $173,000 | -70.4% | 11,554 | -74.1% | 0.00% | – |
| Q4 2016 | $585,000 | +277.4% | 44,656 | +397.8% | 0.00% | – |
| Q3 2016 | $155,000 | -95.8% | 8,970 | -95.6% | 0.00% | -100.0% |
| Q2 2016 | $3,718,000 | +40.2% | 205,972 | +47.5% | 0.00% | 0.0% |
| Q1 2016 | $2,651,000 | -71.7% | 139,623 | -60.2% | 0.00% | -66.7% |
| Q4 2015 | $9,378,000 | +23.2% | 351,207 | +12.6% | 0.01% | +20.0% |
| Q3 2015 | $7,611,000 | -4.9% | 311,929 | +21.5% | 0.01% | 0.0% |
| Q2 2015 | $8,000,000 | +37995.2% | 256,750 | +17754.7% | 0.01% | – |
| Q1 2015 | $21,000 | +31.2% | 1,438 | -10.3% | 0.00% | – |
| Q4 2014 | $16,000 | – | 1,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |